Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Proteomic and phosphoproteomic landscapes of acute myeloid leukemia

Blood(2022)10.1182/blood.2022016033Source: DataRank Database

Proteomic and phosphoproteomic landscapes of acute myeloid leukemia is a dataset published in Blood (2022). On theSindex it has a DataRank of 2.6, placing it in the top 8.3% of the data-sharing corpus. It has been cited 128 times, with 95 citing works in its 1-hop citation network.

Top 8%percentile

2.6DataRank

Ranks in the top 8% for downstream scientific impact

Data paper Open Access128 citations · 95 citing works in its network

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 19.68)OA: hybridTopics (30)Linked Datasets (25)DataCite Reuse (25)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (1/3)

Dataset classification

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 28%Citation Network 72%

Base Score Contribution

0.729

From this paper's citation signal

Citation Network Contribution

1.9

From 73 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 95 citers.

SCD and MTHFD2 inhibitors for high‐risk acute myeloid leukaemia patients, as suggested by ELN2017‐pathway association
Clinical and Translational Medicine20235 citations10 referencesContributes 0.179
Integrative proteogenomic and pharmacological landscape of acute myeloid leukaemia
Science Bulletin20244 citations15 referencesContributes 0.107
Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children
Leukemia202243 citations54 referencesContributes 0.070
Oncoproteomic profiling of AML: moving beyond genomics
Expert Review of Proteomics20224 citations23 referencesContributes 0.070
FLT3-TKD in the prognosis of patients with acute myeloid leukemia: A meta-analysis
Frontiers in Oncology202334 citations56 referencesContributes 0.063

Authors (19)

Qiang Zhang ORCID,Robert W. Sprung ORCID,Ryan B. Day ORCID,Petra Erdmann-Gilmore ORCID,Yang Li ORCID

Live enrichment

PubMed:35895896 PMC:PMC9523374 OpenAlex:https://openalex.org/W4288052446

NHLBI NIH HHS

Grant: T32 HL007088

NCI NIH HHS

Grant: P01 CA101937

NIGMS NIH HHS

Grant: R24 GM136766

NCI NIH HHS

Grant: P30 CA091842

NIGMS NIH HHS

Grant: P41 GM103422

NCI NIH HHS

Grant: R50 CA211782

NCATS NIH HHS

Grant: UL1 TR000448

NCI NIH HHS

Grant: R35 CA197561

FWCI

19.68

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://ashpublications.org/blood/article-pdf/140/13/1533/1922872/bloodbld2022016033.pdf

publisherhttps://ashpublications.org/blood/article-pdf/140/13/1533/1922872/bloodbld2022016033.pdf

journalhttps://doi.org/10.1182/blood.2022016033

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35895896

repositoryhttps://digitalcommons.wustl.edu/oa_4/1345

Fields of Study

Acute Myeloid Leukemia ResearchAdvanced Proteomics Techniques and ApplicationsMolecular Biology Techniques and Applications

MeSH Terms

NucleophosminHumansKetoglutaric AcidsMembrane ProteinsMutationNuclear ProteinsRNA, MessengerSerineLeukemia, Myeloid, Acutesrc-Family KinasesProteomeKaryopherinsProteomicsfms-Like Tyrosine Kinase 3Histone DemethylasesJumonji Domain-Containing Histone Demethylases

Keywords

Myeloid leukemiaPhosphoproteomicsBiologyLeukemiaComputational biologyMedicineCancer researchImmunologyPhosphorylationCell biologyProtein phosphorylation

Additional file 2 of FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

10.6084/m9.figshare.22607363.v1figshare

Additional file 2 of FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

10.6084/m9.figshare.22607363figshare

Additional file 3 of FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

10.6084/m9.figshare.22607366.v1figshare

Additional file 3 of FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

10.6084/m9.figshare.22607366figshare

Additional file 4 of FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

10.6084/m9.figshare.22607369.v1figshare

Additional file 4 of FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

10.6084/m9.figshare.22607369figshare

Additional file 5 of FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

10.6084/m9.figshare.22607372.v1figshare

Additional file 5 of FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

10.6084/m9.figshare.22607372figshare

Additional file 6 of FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

10.6084/m9.figshare.22607375.v1figshare

Additional file 6 of FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

10.6084/m9.figshare.22607375figshare

Additional file 8 of FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

10.6084/m9.figshare.22607381.v1figshare

Additional file 8 of FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

10.6084/m9.figshare.22607381figshare

Additional file 9 of FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

10.6084/m9.figshare.22607384.v1figshare

Additional file 9 of FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

10.6084/m9.figshare.22607384figshare

Additional file 1 of m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia

10.6084/m9.figshare.23993311.v1figshare

Additional file 1 of m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia

10.6084/m9.figshare.23993311figshare

Additional file 2 of m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia

10.6084/m9.figshare.23993314.v1figshare

Additional file 2 of m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia

10.6084/m9.figshare.23993314figshare

Additional file 3 of m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia

10.6084/m9.figshare.23993317.v1figshare

Additional file 3 of m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia

10.6084/m9.figshare.23993317figshare

Related Papers (10)

Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy

N/A

8.1DataRank · unranked

Cell(2020)

co-cited

10.1016/j.cell.2020.10.036

Proteogenomic and metabolomic characterization of human glioblastoma

N/A

8.7DataRank · unranked

Cancer Cell(2021)

co-cited

10.1016/j.ccell.2021.01.006

Proteogenomic characterization of pancreatic ductal adenocarcinoma

N/A

7.9DataRank · unranked

Cell(2021)

co-cited

10.1016/j.cell.2021.08.023

Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

N/A

9.1DataRank · unranked

Cell(2020)

co-cited

10.1016/j.cell.2020.06.013

A proteogenomic portrait of lung squamous cell carcinoma

N/A

7.2DataRank · unranked

Cell(2021)

co-cited

10.1016/j.cell.2021.07.016

Integrative analysis of drug response and clinical outcome in acute myeloid leukemia

N/A

7.1DataRank · unranked

Cancer Cell(2022)

co-cited

10.1016/j.ccell.2022.07.002

Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer

N/A

0.878DataRank · unranked

Cell(2020)

co-cited

10.1016/j.cell.2020.10.044

Automated mass spectrometry imaging of over 2000 proteins from tissue sections at 100-μm spatial resolution

N/A

0.840DataRank · unranked

Nature Communications(2020)

co-cited

10.1038/s41467-019-13858-z

Ultrasensitive single-cell proteomics workflow identifies >1000 protein groups per mammalian cell

Chemical Science(2020)

co-cited

10.1039/d0sc03636f

Rapid and deep-scale ubiquitylation profiling for biology and translational research

N/A

2.6DataRank · unranked

Nature Communications(2020)

co-cited

10.1038/s41467-019-14175-1